期刊
EXPERT OPINION ON INVESTIGATIONAL DRUGS
卷 16, 期 6, 页码 867-876出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/13543784.16.6.867
关键词
APC/WNT; aurora kinase; colon cancer; colorectal cancer; EGFR; erbB/EGFR; Met; Notch; PI3K
Colorectal carcinoma is a leading cause of cancer mortality worldwide. Survival for patients with metastatic disease is similar to 2 years on average and there is an ongoing need for the identification of new therapeutic agents. As the cancer research community has appreciated, newly discovered pathways governing cancer cell growth, survival, apoptosis, invasion and angiogenesis - all a host of potential therapeutic targets - have come into view. Basic research, preclinical data and observations arising from early stage trials have pointed towards possible roles for many of these agents in the future treatment of colorectal cancer. In this review, the authors summarize agents in development, modulating several of the most promising molecules and pathways that are thought to be relevant to colorectal cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据